Table 3.
Association of Male Sex With All-Cause Mortality Among Patients With Tuberculosis, Using Random Effects Meta-analysis
| All-Cause Mortality | ||||||
|---|---|---|---|---|---|---|
| Characteristic | No. of Studies | OR (95% CI) | I 2 Statistic | No. of Studies | HR (95% CI) | I 2 Statistic |
| Unadjusted | ||||||
| All studies | 135 | 1.26 (1.19–1.34) | 77.90 | 44 | 1.17 (1.07–1.27) | 63.59 |
| During treatment | 122 | 1.26 (1.19–1.34) | 71.30 | 26 | 1.16 (1.06–1.27) | 59.72 |
| General setting | 111 | 1.26 (1.19–1.35) | 77.39 | 25 | 1.18 (1.05–1.30) | 66.87 |
| ICU setting | 11 | 0.92 (.71–1.18) | 0 | 1 | 2.57 (.73–9.08) | … |
| During follow-up | 13 | 1.39 (1.09–1.77) | 78.32 | 18 | 1.14 (1.00–1.30) | 60.27 |
| Adjusted | ||||||
| All studies | 52 | 1.31 (1.18–1.45) | 74.80 | 30 | 1.19 (1.05–1.67) | 82.5 |
Abbreviations: CI, confidence interval; HR, hazard ratio; ICU, intensive care unit; OR, odds ratio.
aDuring follow-up after completion of tuberculosis treatment.